Li Gao Selected Research

cyclohexene oxide

10/2017

Zeylenone, a naturally occurring cyclohexene oxide, inhibits proliferation and induces apoptosis in cervical carcinoma cells via PI3K/AKT/mTOR and MAPK/ERK pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li Gao Research Topics

Disease

149	Neoplasms (Cancer) 05/2022 - 10/2002
75	Infections 06/2022 - 01/2004
53	Inflammation (Inflammations) 07/2022 - 11/2006
27	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2022 - 10/2003
22	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2006
21	Nasopharyngeal Carcinoma 01/2022 - 05/2006
21	Carcinoma (Carcinomatosis) 01/2022 - 02/2004
20	Ischemic Stroke 01/2022 - 12/2012
19	Stroke (Strokes) 10/2021 - 04/2012
19	Brain Ischemia (Cerebral Ischemia) 08/2021 - 03/2009
19	Leukemia 01/2021 - 04/2007
16	Ischemia 07/2022 - 01/2008
16	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 11/2002
14	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2004
12	Virus Diseases (Viral Diseases) 09/2022 - 03/2012
12	Marek Disease (Marek's Disease) 09/2022 - 11/2016
12	Asthma (Bronchial Asthma) 12/2020 - 07/2006
12	Sepsis (Septicemia) 06/2020 - 01/2005
11	Carcinogenesis 01/2022 - 01/2009
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 02/2010
11	Fibrosis (Cirrhosis) 09/2021 - 01/2010
11	Infarction (Infarctions) 08/2021 - 05/2009
10	Osteoarthritis 01/2022 - 10/2017
10	Pain (Aches) 01/2022 - 01/2015
10	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2019 - 12/2003
10	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2018 - 05/2009
9	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 07/2005
9	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 05/2012
9	Body Weight (Weight, Body) 08/2021 - 04/2007
9	Reperfusion Injury 10/2018 - 04/2012
8	Squamous Cell Carcinoma of Head and Neck 10/2022 - 07/2017
8	Papillary Thyroid Cancer 01/2022 - 02/2010
8	Acute Kidney Injury (Acute Renal Failure) 09/2021 - 01/2016
8	Acute Lung Injury 01/2018 - 01/2005
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2005
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 10/2003
7	Brain Injuries (Brain Injury) 12/2021 - 03/2009
7	Cognitive Dysfunction 10/2021 - 01/2017
7	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 10/2012
7	Hemorrhage 01/2021 - 10/2003
7	Adenocarcinoma of Lung 01/2021 - 06/2007
7	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 04/2015
7	Pancreatic Neoplasms (Pancreatic Cancer) 04/2020 - 01/2006
7	Hypoxia (Hypoxemia) 01/2020 - 01/2006
7	Hypertension (High Blood Pressure) 01/2020 - 01/2013
7	Wounds and Injuries (Trauma) 01/2019 - 01/2012
6	Necrosis 01/2022 - 03/2005
6	COVID-19 01/2022 - 01/2021
6	Disease Progression 01/2022 - 04/2014
6	Heart Failure 01/2021 - 12/2013
6	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2017
6	Type 2 Diabetes Mellitus (MODY) 11/2020 - 01/2013
6	Breast Neoplasms (Breast Cancer) 03/2020 - 07/2007
6	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 02/2009

Drug/Important Bio-Agent (IBA)

85	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2004
31	Messenger RNA (mRNA)IBA 01/2022 - 01/2004
26	Biomarkers (Surrogate Marker)IBA 02/2022 - 06/2004
26	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2004
26	CytokinesIBA 01/2022 - 05/2005
25	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2010
24	Pharmaceutical PreparationsIBA 10/2021 - 03/2009
21	VaccinesIBA 09/2022 - 03/2012
16	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2007
16	Biological ProductsIBA 01/2021 - 06/2006
14	Small Interfering RNA (siRNA)IBA 01/2021 - 12/2004
13	Cisplatin (Platino)FDA LinkGeneric 10/2022 - 10/2006
12	Therapeutic UsesIBA 01/2022 - 02/2013
11	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2013
11	Transcription Factors (Transcription Factor)IBA 01/2022 - 05/2012
10	AntigensIBA 05/2022 - 05/2007
10	EnzymesIBA 01/2021 - 07/2006
9	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2005
9	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2013
9	CateninsIBA 10/2021 - 10/2013
8	baicaleinIBA 01/2021 - 06/2013
8	Immunoglobulin E (IgE)IBA 12/2020 - 07/2006
8	LipopolysaccharidesIBA 02/2020 - 05/2007
7	Ketamine FDA LinkGeneric 05/2022 - 05/2017
7	Long Noncoding RNAIBA 01/2022 - 01/2017
7	FlavonoidsIBA 08/2021 - 10/2011
7	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2021 - 11/2017
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 06/2013
6	Protein Isoforms (Isoforms)IBA 01/2022 - 04/2006
6	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2016
6	Chimeric Antigen ReceptorsIBA 01/2022 - 07/2018
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2020 - 07/2012
6	Oxygen (Dioxygen)IBA 04/2020 - 01/2008
6	AntioxidantsIBA 01/2020 - 08/2014
6	LipidsIBA 01/2020 - 02/2004

Therapy/Procedure

64	Therapeutics 07/2022 - 02/2004
31	Radiotherapy 10/2022 - 10/2002
30	Drug Therapy (Chemotherapy) 10/2022 - 01/2006
27	Hematopoietic Stem Cell Transplantation 12/2022 - 12/2003
17	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2022 - 06/2006
16	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 05/2009
13	Aftercare (After-Treatment) 01/2022 - 08/2006
11	Transplantation 01/2022 - 01/2008
7	Chemoradiotherapy 10/2022 - 07/2012
7	Thyroidectomy 03/2017 - 10/2003
6	Ligation 01/2021 - 11/2006